Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia

Neuropsychobiology

Volumn 60, Issue 1, 2009, Pages 12-22

  Vohs, Jenifer L ^a   Chambers, R Andrew ^b   Krishnan, Giri P ^a   O'Donnell, Brian F ^a   Hetrick, William P ^a   Kaiser, Samuel T ^b   Berg, Sarah ^b   Morzorati, Sandra L ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Auditory evoked potentials; Electroencephalography; Schizophrenia, animal model; Sensory gating, rats

Indexed keywords

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY MEMORY; BRAIN DAMAGE; CHANNEL GATING; CONTROLLED STUDY; ELECTRODE; ELECTROENCEPHALOGRAM; EVOKED RESPONSE; FEMALE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SCORING SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; AUDITORY PERCEPTION; BETA RHYTHM; DISEASE MODELS, ANIMAL; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; HIPPOCAMPUS; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; THETA RHYTHM; TIME FACTORS;

EID: 68549106216     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000234813     Document Type: Article

References (68)

1. Eccles JC: The Inhibitory Pathways of the Central Nervous System. Liverpool, Liverpool University Press, 1969.
2. Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M: Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 2004; 26: 203-215.
3. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AE, Swerdlow NR: Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophrenia Bull 2007; 33: 1-26.
4. Bramon E, Croft RJ, McDonald C, Virdi GK, Gruzelier JG, Baldeweg T, et al.: Mismatch negativity in schizophrenia: A family study. Schizophrenia Res 2004; 67: 1-10.
5. De Wilde O, Bour L, Dingemans P, Koelman J, Linszen D: A meta-analysis of P50 studies in patients with schizophrenia and relatives: Differences in methodology between research groups. Schizophrenia Res 2007; 97: 137-151.
6. Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H, et al.: P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Res 2008; 58: 226-247.
7. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, et al.: Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 2008b;64: 376-384.
8. Myles-Worsley M: P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry 2004; 55: 663-667.
9. Cadenhead K, Light G, Shafer K, Braff D: P50 suppression in individuals at risk for schizophrenia: The convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 2005; 57: 1504-1509.
10. Bunney WE, Hetrick WP, Bunney BG, Patterson JV, Jin Y, Potkin SG, et al.: Structured interview for assessing perceptual anomalies (SIAPA). Schizophrenia Bull 1999; 25: 577-592.
11. Johannesen JK, Bodkins M, O'Donnell BF, Shekhar A, Hetrick WP: Perceptual anomalies in schizophrenia co-occur with selective impairments in the gamma frequency component of midlatency auditory ERPs. J Abnorm Psychol 2008; 117: 106-118.
12. Braff DL, Geyer MA: Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 1990; 47: 181-188.
13. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R: Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982; 17: 639-654.
14. Boutros NN, Zouridakis G, Overall J: Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 1991; 22: 40-45.
15. Boutros NN, Belger A, Campbell D, D'Souza C, Krystal J: Comparison of four components of sensory gating in schizophrenia and normal subjects: A preliminary report. Psychiatry Res 1999; 88: 119-130.
16. Erwin RJ, Turetsky BL, Moberg P, Gur RC, Gur RE: P50 abnormalities in schizophrenia: Relationship to clinical and neuropsychological indices of attention. Schizophrenia Res 1998; 33: 157-167.
17. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD: Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biol Psychiatry 1983; 18: 537-551.
18. Myles-Worsley M: P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry 2002; 159: 2007-2012.
19. Patterson JV, Jin Y, Gierczak M, Hetrick WP, Potkin S, Bunney WE, Sandman C: Effects of P50 temporal variability on sensory gating in schizophrenia. Arch Gen Psychiatry 2000; 57: 57-64.
20. Stevens KE, Nagamoto H, Johnson RG, Adams CE, Rose GM: Kainic acid lesions in adult rats as a model of schizophrenia: Changes in auditory information processing. Neuroscience 1998; 82: 701-708.
21. Yee CM, Nuechterlein KH, Morris SE, White PM: P50 suppression in recent-onset schizophrenia: Clinical correlates and risperidone effects. J Abnorm Psychol 1998; 107: 691-698.
22. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney WE: Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 1997; 70: 71-81.
23. Zouridakis G, Boutros NN, Jansen BH: A fuzzy clustering approach to study the auditory P50 component in schizophrenia. Psychiatry Res 1997; 69: 169-181.
24. Makeig S, Debener S, Onton J, Delorme A: Mining event-related brain dynamics. Trends Cogn Sci 2004; 8: 204-210.
25. Olejniczak P: Neurophysiologic basis of EEG. J Clin Neurophysiol 2006; 23: 186-189.
26. Jansen BH, Hegde A, Boutros NN: Contribution of different EEG frequencies to auditory evoked potential abnormalities in schizophrenia. Clin Neurophysiol 2004; 115: 523-533.
27. Clementz BA, Blumfield LD: Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia. Exp Brain Res 2001; 139: 377-390.
28. Johannesen JK, Kieffaber PD, O'Donnell BF, Shekhar A, Evans JD, Hetrick WP: Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophrenia Res 2005; 78: 269-284.
29. Brockhause-Dumke A, Mueller R, Faigle U, Klosterkoetter J: Sensory gating revisited: Relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophrenia Res 2008;99: 238-249.
30. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR: Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 1995; 122: 35-43.
31. Lipska BK, Weinberger DR: To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 2000; 23: 223-239.
32. Harrison PJ: The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 2001; 174: 151-162.
33. Steen RG, Mull C, McClure RM, Hamer RM, Lieberman JA: Brain volume in first-episode schizophrenia: Systematic review and metaanalysis of magnetic resonance imaging studies. Br J Psychiatry 2006; 188: 510-518.
34. Chambers RA, Moore J, McEvoy JP, Levin ED: Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 1996; 15: 587-594.
35. Chambers RA, Jones RM, Brown S, Taylor JR: Natural reward related learning in rats with neonatal ventral hippocampal lesions and prior cocaine exposure. Psychopharmacology 2005; 179: 470-478.
36. Al-Amin HA, Weinberger DR, Lipska BK: Exaggerated MK-801-induced motor hyperactivity with the neonatal lesion of the ventral hippocampus. Behav Pharmacol 2000; 11: 269-278.
37. Le Pen G, Moreau JL: Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002; 27: 1-11.
38. Adler LE, Rose G, Freedman R: Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 1986; 21: 787-798.
39. Boutros NN, Bonnet KA, Millana R, Liu J: A parametric study of the N40 auditory evoked response in rats. Biol Psychiatry 1997; 42: 1051-1059.
40. Mears RP, Klein AD, Cromwell HC: Auditory inhibitory gating in medial prefrontal cortex: Single unit and local field potential analysis. Neuroscience 2006; 141: 47-65.
41. Miyazato H, Skinner RD, Crews T, Williams K, Garcia-Rill E: Serotonergic modulation of the P13 midlatency auditory evoked potential in the rat. Brain Res Bull 2000; 51: 387-391.
42. Phillips JM, Ehrlichman RS, Siegel SJ: Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Neuroscience 2007; 144: 1314-1323.
43. Boutros NN, Uretski NJ, Berntson G, Bornstein R: Effects of cocaine on the sensory inhibitory capacity in rats: A preliminary study. Biol Psychiatry 1994; 36: 242-248.
44. Boutros NN, Kwan SW: Test-retest reliability of the rat N40 auditory evoked response: Preliminary data. Psychiatry Res 1998; 81: 269-276.
45. Stevens KE, Fuller LL, Rose GM: Dopaminergic and noradrenergic modulation of amphetamine- induced changes in auditory gating. Brain Res 1991; 555: 91-98.
46. Stevens KE, Meltzer J, Rose GM: Nicotinic cholinergic normalization of amphetamineinduced loss of auditory gating in freely moving rats. Psychopharmacology (Berl) 1995; 119: 163-170.
47. Umbricht D, Vyssotky D, Latanov A, Nitsch R, Brambilla R, D'Adamo P, Lipp HP: Midlatency auditory event-related potentials in mice: Comparison to midlatency auditory ERPs in humans. Brain Res 2004; 1019: 189-200.
48. DeBruin NM, Ellenbroek BA, van Luijtelaar EL, Cools AR, Stevens KE: Hippocampal and cortical sensory gating in rats: Effects of quinpirole microinjection in nucleus accumbens core and shell. Neuroscience 2001; 105: 169-180.
49. Joy B, McMahon RP, Shepard PD: Effects of acute and chronic clozapine on D -amphetamine- induced disruption of auditory gating in the rat. Psychopharmacology 2004; 174: 274-282.
50. Salamy A, Salfi M, Fein G: Sensory gating deficit following cocaine exposure in the rat. Biol Psychol Pharmacopsychol 1997; 36: 83-86.
51. Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, et al.: Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 2006; 31: 506-515.
52. Freedman R, Waldo M, Bickford-Winner P, Nagamoto H: Elementary neuronal dysfunction in schizophrenia. Schizophrenia Res 1991; 4: 233-243.
53. Moxon KA, Gerhardt GA, Adler LE: Dopaminergic modulation of the P50 auditoryevoked potential in a computer model of the CA3 region of the hippocampus: Its relationship to sensory gating in schizophrenia. Biol Cybern 2003; 88: 265-275.
54. Korzyukov O, Pflieger ME, Wagner M, Bowyer SM, Rosburg T, Sundaresan K, et al.: Generators of the intracranial P50 response in auditory sensory gating. Neuroimage 2007; 35: 814-826.
55. Weisser R, Weisbrod M, Roehrig M, Rupp A, Schroeder J, Scherg M: Is frontal lobe involved in the generation of the auditory evoked P50? Neuroreport 2001; 12: 3303-3307.
56. Makeig S: Auditory event-related dynamics of the EEG spectrum and effects of exposure to tones. Electroencephalogr Clin Neurophysiol 1993; 86: 283-293.
57. Tallon-Baudy C, Bertrand O, Delpuech C, Pernier J: Stimulus specificity of phaselocked and non-phase-locked 40 Hz visual responses in human. J Neurosci 1996; 16: 4240-4249.
58. Pierce CA, Block RA, Aguinis H: Cautionary note on reporting eta-squared values from multifactor ANOVA designs. Educ Psychol Meas 2004; 64: 916-924.
59. Nagamoto H, Adler L, Walkdo M, Freedman R: Sensory gating in schizophrenics and normal controls: Effects of changing stimulus interval. Biol Psychiatry 1989; 25: 549-561.
60. Grunwald T, Boutros NN, Pezer N, von Oertzen J, Fernandez G, Schaller C, et al.: Neuronal substrates of sensory gating within the human brain. Biol Psychiatry 2003; 53: 511-519.
61. Young CK, McNaughton N: Coupling of theta oscillations between anterior and posterior midline cortex and with the hippocampus in freely behaving rats. Cereb Cortex 2009; 19: 24-40.
62. Hong LE, Summerfelt A, Mitchell BD, Mc- Mahon RP, Wonodi I, Buchanan RW, Thaker GK: Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate. Arch Gen Psychiatry 2008; 65: 1008-1016.
63. Karakas S, Basar E: Early gamma response is sensory in origin: A conclusion based on cross-comparison of results from multiple experimental paradigms. Int J Psychophysiol 1998; 31: 13-31.
64. Boutros NN, Mears R, Plieger ME, Moxon KA, Ludowig E, Rosburg T: Sensory gating in the human hippocampal and rhinal regions: Regional differences. Hippocampus 2008; 18: 310-316.
65. Bickford-Wimer PC, Nagamoto H, Johnson R, Adler LE, Egan M, Rose GM, Freedman R: Auditory sensory gating in hippocampal neurons: A model system in the rat. Biol Psychiatry 1990; 27: 183-192.
66. Simpson GV, Knight RT: Multiple brain systems generating rat auditory evoked potential. I. Characterization of the auditory cortex response. Brain Res 1993; 602: 240-250.
67. Schridde U, van Luijtelaar G: The role of hippocampal theta activity in sensory gating in the rat. Physiol Behav 2000; 74: 257-266.
68. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK: Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 2002; 12: 975-982.